These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26480686)

  • 1. [Animal models of myasthenia gravis].
    Shigemoto K; Takashima R; Motohashi N; Mori S
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():97-104. PubMed ID: 26480686
    [No Abstract]   [Full Text] [Related]  

  • 2. Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies.
    Tsivgoulis G; Dervenoulas G; Tzartos SJ; Zompola C; Papageorgiou SG; Voumvourakis K
    Muscle Nerve; 2014 Jun; 49(6):930-1. PubMed ID: 24638957
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
    Abramsky O
    Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 6. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathogenesis and treatment of myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP
    J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
    Chiu HC; Chen ML; Tsai MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
    Członkowski A; Członkowska A
    Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):383-7. PubMed ID: 6101172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
    Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
    J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies in myasthenia gravis].
    Motomura M; Narita Masuda T
    Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody to acetylcholine receptors in human MG.
    Lindstrom J
    Int J Neurol; 1980; 14(1):17-24. PubMed ID: 6293988
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.